These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 8907211

  • 1. Reversibility of atherosclerosis--evolving perspectives from two arterial imaging clinical trials: the cholesterol lowering atherosclerosis regression study and the monitored atherosclerosis regression study.
    Hodis HN.
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S25-31. PubMed ID: 8907211
    [Abstract] [Full Text] [Related]

  • 2. George Lyman Duff Memorial Lecture. Arterial imaging and atherosclerosis reversal.
    Blankenhorn DH, Hodis HN.
    Arterioscler Thromb; 1994 Feb; 14(2):177-92. PubMed ID: 8305407
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of two lipid-lowering treatments on quantitative coronary angiographic endpoints.
    Mack WJ, Xiang M, Shircore AM, Selzer RH, Hodis HN, Azen SP.
    Cardiovasc Drugs Ther; 2000 Aug; 14(4):411-8. PubMed ID: 10999648
    [Abstract] [Full Text] [Related]

  • 4. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.
    Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT.
    N Engl J Med; 1990 Nov 08; 323(19):1289-98. PubMed ID: 2215615
    [Abstract] [Full Text] [Related]

  • 5. Triglyceride-rich lipoproteins and progression of atherosclerosis.
    Hodis HN, Mack WJ.
    Eur Heart J; 1998 Feb 08; 19 Suppl A():A40-4. PubMed ID: 9519342
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness.
    Hodis HN, Mack WJ, Dunn M, Liu C, Liu C, Selzer RH, Krauss RM.
    Circulation; 1997 Apr 15; 95(8):2022-6. PubMed ID: 9133510
    [Abstract] [Full Text] [Related]

  • 11. Serial quantitative coronary angiography and coronary events.
    Mack WJ, Xiang M, Selzer RH, Hodis HN.
    Am Heart J; 2000 Jun 15; 139(6):993-9. PubMed ID: 10827379
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of colestipol-niacin therapy on human femoral atherosclerosis.
    Blankenhorn DH, Azen SP, Crawford DW, Nessim SA, Sanmarco ME, Selzer RH, Shircore AM, Wickham EC.
    Circulation; 1991 Feb 15; 83(2):438-47. PubMed ID: 1991366
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group.
    Frick MH, Syvänne M, Nieminen MS, Kauma H, Majahalme S, Virtanen V, Kesäniemi YA, Pasternack A, Taskinen MR.
    Circulation; 1997 Oct 07; 96(7):2137-43. PubMed ID: 9337181
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Retardation of coronary atherosclerosis: the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and other angiographic trials.
    de Faire U, Ericsson CG, Grip L, Nilsson J, Svane B, Hamsten A.
    Cardiovasc Drugs Ther; 1997 May 07; 11 Suppl 1():257-63. PubMed ID: 9211018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.